Skip to main content
SpringerLink
Log in

Community-Based Interventions for HPV Vaccination

  • Chapter
  • First Online:
Cancer Health Disparities

  • 122 Accesses

Abstract

Multiple disparities exist in human papillomavirus (HPV)-related cancers and HPV vaccination series initiation and completion in the USA. This chapter highlights community-based intervention research aimed at increasing HPV vaccination and addressing these disparities. First, the chapter provides an overview of HPV, HPV-related cancers, and HPV vaccination, including current recommendations from health and professional organizations, as well as trends in uptake in the USA. Next, the chapter describes HPV vaccination rates and unique challenges, barriers, and facilitators to vaccination among multiple US population groups that experience HPV-related disparities. Population groups featured in the chapter include individuals who live in rural areas, those who are medically underserved with limited financial resources, those who are from racial/ethnic minority groups, those who were born outside of the USA, those aged 18–26 years, and those who identify as being from sexual and gender minority groups. Findings from intervention research conducted among these specific population groups and in novel settings are also described. Finally, gaps in the literature and directions for future community-based research studies are identified.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Satterwhite CL, Torrone E, Meites E, et al. Sexually transmitted infections among US women and men: prevalence and incidence estimates, 2008. Sex Transm Dis. 2013;40(3):187–93.

    Article  PubMed  Google Scholar 

  2. IARC. Human papillomaviruses. IARC. 2012;100:255–313.

    Google Scholar 

  3. Centers for Disease Control. Human Papillomavirus (HPV). 2019. https://www.cdc.gov/hpv/index.html

  4. Cogliano V, Baan R, Grosse Y, Secretan B, Ghissassi F. Carcinogenicity of human papillomaviruses. Lancet Oncol. 2005;6(4):204.

    Google Scholar 

  5. National Cancer Institute. HPV and cancer. 2019. https://www.cancer.gov/about-cancer/causes-prevention/risk/infectious-agents/hpv-and-cancer

  6. Senkomago V, Henley SJ, Thomas CC, Mix JM, Markowitz LE, Saraiya M. Human papillomavirus–attributable cancers—United States, 2012–2016. Morb Mortal Wkly Rep. 2019;68(33):724.

    Article  Google Scholar 

  7. Van Dyne EA, Henley SJ, Saraiya M, Thomas CC, Markowitz LE, Benard VB. Trends in human papillomavirus–associated cancers—United States, 1999–2015. Morb Mortal Wkly Rep. 2018;67(33):918.

    Article  Google Scholar 

  8. Zahnd WE, James AS, Jenkins WD, et al. Rural–urban differences in cancer incidence and trends in the United States. Cancer Epidemiol Biomarkers Prev. 2018;27(11):1265–74.

    Article  PubMed  Google Scholar 

  9. Sudenga SL, Nyitray AG, Torres BN, et al. Comparison of anal HPV natural history among men by country of residence: Brazil, Mexico, and the United States. J Infect. 2017;75(1):35–47.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Markowitz LE, Gee J, Chesson H, Stokley S. Ten years of human papillomavirus vaccination in the United States. Acad Pediatr. 2018;18(2):S3–S10.

    Article  PubMed  Google Scholar 

  11. U.S. Food & Drug Adminstration. Approval letter – ceravix. 2009.

    Google Scholar 

  12. U.S. Food & Drug Administration. Approval letter – human papillomavirus quadrivalent (Types 6, 11, 16, 18) vaccine, recombinant. 2006.

    Google Scholar 

  13. U.S. Food & Drug Administration. Approval letter – gardasil. 2009.

    Google Scholar 

  14. U.S. Food & Drug Administration. Approval letter – GARDASIL 9. 2014.

    Google Scholar 

  15. Services Dohah. Supplement approval for human papillomavirus 9-valent vaccine, recombinant. 2015.

    Google Scholar 

  16. U.S. Food & Drug Administration. Supplement approval, human papillomavirus 9-valent, recombinant, Ages 27–45. 2018.

    Google Scholar 

  17. Meites E, Szilagyi PG, Chesson HW, Unger ER, Romero JR, Markowitz LE. Human papillomavirus vaccination for adults: updated recommendations of the Advisory Committee on Immunization Practices. Am J Transplant. 2019;19(11):3202–6.

    Article  Google Scholar 

  18. Meites E. Human papillomavirus vaccination for adults: updated recommendations of the Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep. 2019;68:698–702.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Meites E. Use of a 2-dose schedule for human papillomavirus vaccination—updated recommendations of the Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep. 2016;65

    Google Scholar 

  20. Boersma P, Black LI. Human papillomavirus vaccination among adults aged 18–26, 2013–2018. NCHS Data Brief. 2020;(354):1–8.

    Google Scholar 

  21. Walker TY, Elam-Evans LD, Yankey D, et al. National, regional, state, and selected local area vaccination coverage among adolescents aged 13–17 years—United States, 2018. Morb Mortal Wkly Rep. 2019;68(33):718.

    Article  Google Scholar 

  22. Centers for Disease Control. TeenVaxView | 2018 adolescent HPV vaccination coverage report. Atlanta: CDC; 2019.

    Google Scholar 

  23. HPV Roundtable. School entry requirements for HPV vaccine. 2019.

    Google Scholar 

  24. Skinner EG, Alise. HPV vaccine: State Legislation and Regulation. 2020. https://www.ncsl.org/research/health/hpv-vaccine-state-legislation-and-statutes.aspx

  25. Spencer JC, Calo WA, Brewer NT. Disparities and reverse disparities in HPV vaccination: a systematic review and meta-analysis. Prev Med. 2019;123:197–203.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Reiter PL, Cates JR, McRee A-L, et al. Statewide HPV vaccine initiation among adolescent females in North Carolina. Sex Transm Dis. 2010;37(9):549.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Staras SA, Vadaparampil ST, Haderxhanaj LT, Shenkman EA. Disparities in human papillomavirus vaccine series initiation among adolescent girls enrolled in Florida Medicaid programs, 2006–2008. J Adolesc Health. 2010;47(4):381–8.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Curtis CR, Dorell C, Yankey D, et al. National human papillomavirus vaccination coverage among adolescents aged 13–17 years—National Immunization Survey–Teen, United States, 2011. MMWR Surveill Summ. 2014;63(Suppl 2):61–70.

    Google Scholar 

  29. Henry KA, Stroup AM, Warner EL, Kepka D. Geographic factors and human papillomavirus (HPV) vaccination initiation among adolescent girls in the United States. Cancer Epidemiol Prev Biomarkers. 2016;25(2):309–17.

    Article  Google Scholar 

  30. Vielot NA, Butler AM, Brookhart MA, Becker-Dreps S, Smith JS. Patterns of use of human papillomavirus and other adolescent vaccines in the United States. J Adolesc Health. 2017;61(3):281–7.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Henry KA, Swiecki-Sikora AL, Stroup AM, Warner EL, Kepka D. Area-based socioeconomic factors and human papillomavirus (HPV) vaccination among teen boys in the United States. BMC Public Health. 2018;18(1):19.

    Article  Google Scholar 

  32. Williams CL, Walker TY, Elam-Evans LD, et al. Factors associated with not receiving HPV vaccine among adolescents by metropolitan statistical area status, United States, National Immunization Survey–Teen, 2016–2017. Hum Vaccin Immunother. 2020;16(3):562–72.

    Article  PubMed  Google Scholar 

  33. Douthit N, Kiv S, Dwolatzky T, Biswas S. Exposing some important barriers to health care access in the rural USA. Public Health. 2015;129(6):611–20.

    Article  CAS  PubMed  Google Scholar 

  34. Luque J, Raychowdhury S, Weaver M. Health care provider challenges for reaching Hispanic immigrants with HPV vaccination in rural Georgia. Rural Remote Health. 2012;12(2):1975.

    Google Scholar 

  35. Allison MA, Dunne EF, Markowitz LE, et al. HPV vaccination of boys in primary care practices. Acad Pediatr. 2013;13(5):466–74.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Boyd ED, Phillips JM, Schoenberger Y-MM, Simpson T. Barriers and facilitators to HPV vaccination among rural Alabama adolescents and their caregivers. Vaccine. 2018;36(28):4126–33.

    Article  PubMed  Google Scholar 

  37. Moss JL, Gilkey MB, Rimer BK, Brewer NT. Disparities in collaborative patient-provider communication about human papillomavirus (HPV) vaccination. Hum Vaccin Immunother. 2016;12(6):1476–83.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Buchwald D, Muller C, Bell M, Schmidt-Grimminger D. Attitudes toward HPV vaccination among rural American Indian women and urban white women in the northern plains. Health Educ Behav. 2013;40(6):704–11.

    Article  PubMed  Google Scholar 

  39. Reiter PL, Brewer NT, Gottlieb SL, McRee A-L, Smith JS. Parents’ health beliefs and HPV vaccination of their adolescent daughters. Soc Sci Med. 2009;69(3):475–80.

    Article  PubMed  Google Scholar 

  40. Cartmell KB, Young-Pierce J, McGue S, et al. Barriers, facilitators, and potential strategies for increasing HPV vaccination: a statewide assessment to inform action. Papillomavirus Res. 2018;5:21–31.

    Article  PubMed  Google Scholar 

  41. Kepka DL, Ulrich AK, Coronado GD. Low knowledge of the three-dose HPV vaccine series among mothers of rural Hispanic adolescents. J Health Care Poor Underserved. 2012;23(2):626–35.

    Article  PubMed  Google Scholar 

  42. Mohammed KA, Subramaniam DS, Geneus CJ, et al. Rural-urban differences in human papillomavirus knowledge and awareness among US adults. Prev Med. 2018;109:39–43.

    Article  PubMed  Google Scholar 

  43. Tiggelaar SM, Rafalski M, Davidson MA, Hu Y, Burnett L. HPV knowledge and vaccine acceptability in Appalachian Tennessee and Kentucky, USA. J Fam Plann Reprod Health Care. 2014;40(1):75–6.

    Article  PubMed  Google Scholar 

  44. Vanderpool RC, Dressler EVM, Stradtman LR, Crosby RA. Fatalistic beliefs and completion of the HPV vaccination series among a sample of young Appalachian Kentucky women. J Rural Health. 2015;31(2):199–205.

    Article  PubMed  PubMed Central  Google Scholar 

  45. Vanderpool RC, Huang B, Deng Y, et al. Cancer-related beliefs and perceptions in Appalachia: findings from 3 states. J Rural Health. 2019;35(2):176–88.

    Article  PubMed  PubMed Central  Google Scholar 

  46. Thomas TL, Caldera M, Maurer J. A short report: parents HPV vaccine knowledge in rural South Florida. Hum Vaccin Immunother. 2019;15(7–8):1666–71.

    Article  PubMed  PubMed Central  Google Scholar 

  47. Vanderpool RC, Breheny PJ, Tiller PA, et al. Implementation and evaluation of a school-based human papillomavirus vaccination program in rural Kentucky. Am J Prev Med. 2015;49(2):317–23.

    Article  PubMed  Google Scholar 

  48. Vanderpool RC, Casey BR, Crosby RA. HPV-related risk perceptions and HPV vaccine uptake among a sample of young rural women. J Community Health. 2011;36(6):903.

    Article  PubMed  Google Scholar 

  49. Crosby RA, Casey BR, Vanderpool R, Collins T, Moore GR. Uptake of free HPV vaccination among young women: a comparison of rural versus urban rates. J Rural Health. 2011;27(4):380–4.

    Article  PubMed  PubMed Central  Google Scholar 

  50. Cates JR, Shafer A, Diehl SJ, Deal AM. Evaluating a county-sponsored social marketing campaign to increase mothers’ initiation of HPV vaccine for their preteen daughters in a primarily rural area. Soc Mark Q. 2011;17(1):4–26.

    Article  Google Scholar 

  51. Chung RJ, Walter EB, Kemper AR, Dayton A. Keen on teen vaccines: improvement of adolescent vaccine coverage in rural North Carolina. J Adolesc Health. 2015;56(5):S14–6.

    Article  PubMed  Google Scholar 

  52. Paskett ED, Krok-Schoen JL, Pennell ML, et al. Results of a multilevel intervention trial to increase human papillomavirus (HPV) vaccine uptake among adolescent girls. Cancer Epidemiol Biomarkers Prev. 2016;25(4):593–602.

    Google Scholar 

  53. Katz ML, Paskett ED. The process of engaging members from two underserved populations in the development of interventions to promote the uptake of the HPV vaccine. Health Promot Pract. 2015;16(3):443–53.

    Article  PubMed  Google Scholar 

  54. Health Resources and Services Administration. What is shortage designation? 2021. https://bhw.hrsa.gov/workforce-shortage-areas/shortage-designation

  55. Cowburn S, Carlson M, Lapidus J, Heintzman J, Bailey S, DeVoe J. Insurance continuity and human papillomavirus vaccine uptake in Oregon and California federally qualified health centers. Am J Public Health. 2014;104(9):e71–9.

    Article  PubMed  PubMed Central  Google Scholar 

  56. Gerend MA, Zapata C, Reyes E. Predictors of human papillomavirus vaccination among daughters of low-income Latina mothers: the role of acculturation. J Adolesc Health. 2013;53(5):623–9.

    Article  PubMed  Google Scholar 

  57. Moss JL, Reiter PL, Dayton A, Brewer NT. Increasing adolescent immunization by webinar: a brief provider intervention at federally qualified health centers. Vaccine. 2012;30(33):4960–3.

    Article  PubMed  Google Scholar 

  58. Perkins RB, Zisblatt L, Legler A, Trucks E, Hanchate A, Gorin SS. Effectiveness of a provider-focused intervention to improve HPV vaccination rates in boys and girls. Vaccine. 2015;33(9):1223–9.

    Article  PubMed  Google Scholar 

  59. Flores YN, Salmeron J, Glenn BA, Lang CM, Chang LC, Bastani R. Clinician offering is a key factor associated with HPV vaccine uptake among Mexican mothers in the USA and Mexico: a cross-sectional study. Int J Public Health. 2019;64(3):323–32.

    Article  PubMed  Google Scholar 

  60. Colon-Lopez V, Toro-Mejias LM, Conde-Toro A, et al. Views on HPV and HPV vaccination: the experience at a Federal Qualified Clinic in Puerto Rico. J Health Care Poor Underserved. 2016;27(3):1411–26.

    Article  PubMed  PubMed Central  Google Scholar 

  61. VanderVeen N, Wieneke A, Tran S, Kim A, Davis K, Taubel D. Perceived barriers and trends in HPV vaccination via patient survey responses at Kalamazoo, Michigan’s federally-qualified health center. J Community Health. 2020;45(1):48–54.

    Article  PubMed  Google Scholar 

  62. Fisher-Borne M, Preiss AJ, Black M, Roberts K, Saslow D. Early outcomes of a multilevel human papillomavirus vaccination pilot intervention in federally qualified health centers. Acad Pediatr. 2018;18(2S):S79–84.

    Article  PubMed  Google Scholar 

  63. Sandri KJ, Verdenius I, Bartley MJ, et al. Urban and rural safety net health care system clinics: no disparity in HPV4 vaccine completion rates. PLoS One. 2014;9(5):e96277.

    Article  PubMed  PubMed Central  Google Scholar 

  64. Tiro JA, Pruitt SL, Bruce CM, et al. Multilevel correlates for human papillomavirus vaccination of adolescent girls attending safety net clinics. Vaccine. 2012;30(13):2368–75.

    Article  PubMed  Google Scholar 

  65. Bastani R, Glenn BA, Tsui J, et al. Understanding suboptimal human papillomavirus vaccine uptake among ethnic minority girls. Cancer Epidemiol Biomark Prev. 2011;20(7):1463–72.

    Article  Google Scholar 

  66. Perkins RB, Brogly SB, Adams WG, Freund KM. Correlates of human papillomavirus vaccination rates in low-income, minority adolescents: a multicenter study. J Women’s Health (2002). 2012;21(8):813–20.

    Article  Google Scholar 

  67. Cook RL, Zhang J, Mullins J, et al. Factors associated with initiation and completion of human papillomavirus vaccine series among young women enrolled in Medicaid. J Adolesc Health. 2010;47(6):596–9.

    Article  PubMed  Google Scholar 

  68. Agawu A, Buttenheim AM, Taylor L, Song L, Fiks AG, Feemster KA. Sociodemographic differences in human papillomavirus vaccine initiation by adolescent males. J Adolesc Health. 2015;57(5):506–14.

    Article  PubMed  Google Scholar 

  69. Staras SA, Vadaparampil ST, Livingston MD, Thompson LA, Sanders AH, Shenkman EA. Increasing human papillomavirus vaccine initiation among publicly insured Florida adolescents. J Adolesc Health. 2015;56(5 Suppl):S40–6.

    Article  PubMed  PubMed Central  Google Scholar 

  70. Heintzman J, Hatch B, Coronado G, et al. Role of race/ethnicity, language, and insurance in use of cervical cancer prevention services among low-income Hispanic women, 2009–2013. Prev Chronic Dis. 2018;15:E25.

    Article  PubMed  PubMed Central  Google Scholar 

  71. Ng J, Ye F, Roth L, et al. Human papillomavirus vaccination coverage among female adolescents in managed care plans – United States, 2013. MMWR Morb Mortal Wkly Rep. 2015;64(42):1185–9.

    Article  PubMed  Google Scholar 

  72. Staras SA, Vadaparampil ST, Patel RP, Shenkman EA. Parent perceptions important for HPV vaccine initiation among low income adolescent girls. Vaccine. 2014;32(46):6163–9.

    Article  PubMed  PubMed Central  Google Scholar 

  73. Tiro JA, Sanders JM, Pruitt SL, et al. Promoting HPV vaccination in safety-net clinics: a randomized trial. Pediatrics. 2015;136(5):850–9.

    Article  PubMed  Google Scholar 

  74. Inguva S, Barnard M, Ward LM, et al. Factors influencing human papillomavirus (HPV) vaccination series completion in Mississippi Medicaid. Vaccine. 2020;38(8):2051–7.

    Article  CAS  PubMed  Google Scholar 

  75. Centers for Disease Control and Prevention. VFC detailed questions and answers for parents. CDC. 2014 [updated Dec 17, 2014].

    Google Scholar 

  76. Centers for Disease Control and Prevention. VFC Childhood Vaccine Supply Policy 2009. CDC 2009.

    Google Scholar 

  77. Malo TL, Staras SA, Bynum SA, Giuliano AR, Shenkman EA, Vadaparampil ST. Human papillomavirus vaccine administration among Medicaid providers who consistently recommended vaccination. Sex Transm Dis. 2014;41(1):24–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  78. Gowda C, Dempsey AF. Medicaid reimbursement and the uptake of adolescent vaccines. Vaccine. 2012;30(9):1682–9.

    Article  PubMed  Google Scholar 

  79. Agawu A, Hanlon AL, Buttenheim AM, Song L, Fiks AG, Feemster KA. Disparities in human papillomavirus vaccine series completion by adolescent males: a retrospective cohort study. Acad Pediatr. 2020;20(3):364–73.

    Article  PubMed  Google Scholar 

  80. Mills LA, Head KJ, Vanderpool RC. HPV vaccination among young adult women: a perspective from Appalachian Kentucky. Prev Chronic Dis. 2013;10:E17.

    Article  PubMed  PubMed Central  Google Scholar 

  81. Baldwin AS, Denman DC, Sala M, et al. Translating self-persuasion into an adolescent HPV vaccine promotion intervention for parents attending safety-net clinics. Patient Educ Couns. 2017;100(4):736–41.

    Article  PubMed  Google Scholar 

  82. Rand CM, Brill H, Albertin C, et al. Effectiveness of centralized text message reminders on human papillomavirus immunization coverage for publicly insured adolescents. J Adolesc Health. 2015;56(5 Suppl):S17–20.

    Article  PubMed  Google Scholar 

  83. Richman AR, Torres E, Wu Q, et al. Text and email messaging for increasing human papillomavirus vaccine completion among uninsured or Medicaid-insured adolescents in rural eastern North Carolina. J Health Care Poor Underserved. 2019;30(4):1499–517.

    Article  PubMed  Google Scholar 

  84. Sanderson M, Canedo JR, Khabele D, et al. Pragmatic trial of an intervention to increase human papillomavirus vaccination in safety-net clinics. BMC Public Health. 2017;17(1):158.

    Article  PubMed  PubMed Central  Google Scholar 

  85. Bynum SA, Brandt HM, Sharpe PA, Williams MS, Kerr JC. Working to close the gap: identifying predictors of HPV vaccine uptake among young African American women. J Health Care Poor Underserved. 2011;22(2):549–61.

    Article  PubMed  Google Scholar 

  86. Glenn BA, Tsui J, Singhal R, et al. Factors associated with HPV awareness among mothers of low-income ethnic minority adolescent girls in Los Angeles. Vaccine. 2015;33(2):289–93.

    Article  PubMed  Google Scholar 

  87. Adjei Boakye E, Tobo BB, Rojek RP, Mohammed KA, Geneus CJ, Osazuwa-Peters N. Approaching a decade since HPV vaccine licensure: racial and gender disparities in knowledge and awareness of HPV and HPV vaccine. Hum Vaccin Immunother. 2017;13(11):2713–22.

    Article  PubMed  PubMed Central  Google Scholar 

  88. Ojeaga A, Alema-Mensah E, Rivers D, Azonobi I, Rivers B. Racial disparities in HPV-related knowledge, attitudes, and beliefs among African American and white women in the USA. J Cancer Educ. 2019;34(1):66–72.

    Article  PubMed  PubMed Central  Google Scholar 

  89. Gilkey MB, McRee A-L. Provider communication about HPV vaccination: a systematic review. Hum Vaccin Immunother. 2016;12(6):1454–68.

    Article  PubMed  PubMed Central  Google Scholar 

  90. Ylitalo KR, Lee H, Mehta NK. Health care provider recommendation, human papillomavirus vaccination, and race/ethnicity in the US National Immunization Survey. Am J Public Health. 2013;103(1):164–9.

    Article  PubMed  PubMed Central  Google Scholar 

  91. Burdette AM, Webb NS, Hill TD, Jokinen-Gordon H. Race-specific trends in HPV vaccinations and provider recommendations: persistent disparities or social progress? Public Health. 2017;142:167–76.

    Article  PubMed  Google Scholar 

  92. Amboree TL, Darkoh C. Barriers to human papillomavirus vaccine uptake among racial/ethnic minorities: a systematic review. J Racial Ethn Health Disparities. 2020;8:1–16.

    Google Scholar 

  93. Agénor M, Abboud S, Delgadillo JG, Pérez AE, Peitzmeier SM, Borrero S. Intersectional nativity and racial/ethnic disparities in human papillomavirus vaccination initiation among US women: a national population-based study. Cancer Causes Control. 2018;29(10):927–36.

    Article  PubMed  Google Scholar 

  94. Cofie LE, Hirth JM, Guo F, Berenson AB, Markides K, Wong R. HPV vaccination among foreign-born women: examining the National Health Interview Survey 2013–2015. Am J Prev Med. 2018;54(1):20–7.

    Article  PubMed  Google Scholar 

  95. Jacobs EA, Rolle I, Ferrans CE, Whitaker EE, Warnecke RB. Understanding African Americans’ views of the trustworthiness of physicians. J Gen Intern Med. 2006;21(6):642.

    Article  PubMed  PubMed Central  Google Scholar 

  96. Otanez S, Torr BM. Ethnic and racial disparities in HPV vaccination attitudes. J Immigr Minor Health. 2018;20(6):1476–82.

    Article  PubMed  Google Scholar 

  97. Parra-Medina D, Morales-Campos DY, Mojica C, Ramirez AG. Promotora outreach, education and navigation support for HPV vaccination to Hispanic women with unvaccinated daughters. J Cancer Educ. 2015;30(2):353–9.

    Article  PubMed  PubMed Central  Google Scholar 

  98. Valdez A, Stewart SL, Tanjasari SP, Levy V, Garza A. Design and efficacy of a multilingual, multicultural HPV vaccine education intervention. J Commun Healthc. 2015;8(2):106–18.

    Article  PubMed  PubMed Central  Google Scholar 

  99. Joseph NP, Bernstein J, Pelton S, et al. Brief client-centered motivational and behavioral intervention to promote HPV vaccination in a hard-to-reach population: a pilot randomized controlled trial. Clin Pediatr. 2016;55(9):851–9.

    Article  Google Scholar 

  100. Staples JN, Wong MS, Rimel B. An educational intervention to improve human papilloma virus (HPV) and cervical cancer knowledge among African American college students. Gynecol Oncol. 2018;149(1):101–5.

    Article  PubMed  Google Scholar 

  101. Mora AS, Madrigal JM, Jordan L, Patel A. Effectiveness of an educational intervention to increase human papillomavirus knowledge in high-risk minority women. J Low Genit Tract Dis. 2018;22(4):288–94.

    Article  Google Scholar 

  102. McGaffey A, Lombardo NP, Lamberton N, et al. A “sense”-ational HPV vaccination quality improvement project in a family medicine residency practice. J Natl Med Assoc. 2019;111(6):588–99.

    PubMed  Google Scholar 

  103. Mulye TP, Park MJ, Nelson CD, Adams SH, Irwin CE Jr, Brindis CD. Trends in adolescent and young adult health in the United States. J Adolesc Health. 2009;45(1):8–24.

    Article  PubMed  Google Scholar 

  104. Finer LB, Philbin JM. Trends in ages at key reproductive transitions in the United States, 1951–2010. Womens Health Issues. 2014;24(3):e271–9.

    Article  PubMed  PubMed Central  Google Scholar 

  105. Newman PA, Logie CH, Doukas N, Asakura K. HPV vaccine acceptability among men: a systematic review and meta-analysis. Sex Transm Infect. 2013;89(7):568–74.

    Article  PubMed  Google Scholar 

  106. Rosenthal S, Weiss TW, Zimet GD, Ma L, Good M, Vichnin M. Predictors of HPV vaccine uptake among women aged 19–26: importance of a physician’s recommendation. Vaccine. 2011;29(5):890–5.

    Article  CAS  PubMed  Google Scholar 

  107. Laz TH, Rahman M, Berenson AB. Human papillomavirus vaccine uptake among 18-to 26-year-old women in the United States: National Health Interview Survey, 2010. Cancer. 2013;119(7):1386–92.

    Article  PubMed  Google Scholar 

  108. Leung SOA, Akinwunmi B, Elias KM, Feldman S. Educating healthcare providers to increase human papillomavirus (HPV) vaccination rates: a qualitative systematic review. Vaccine: X. 2019;3:100037.

    PubMed  Google Scholar 

  109. Agénor M, Krieger N, Austin SB, Haneuse S, Gottlieb BR. Sexual orientation disparities in Papanicolaou test use among US women: the role of sexual and reproductive health services. Am J Public Health. 2014;104(2):e68–73.

    Article  PubMed  PubMed Central  Google Scholar 

  110. Smulian EA, Mitchell KR, Stokley S. Interventions to increase HPV vaccination coverage: a systematic review. Hum Vaccin Immunother. 2016;12(6):1566–88.

    Article  PubMed  PubMed Central  Google Scholar 

  111. Barnard M, Cole AC, Ward L, Gravlee E, Cole ML, Compretta C. Interventions to increase uptake of the human papillomavirus vaccine in unvaccinated college students: a systematic literature review. Prev Med Rep. 2019;14:100884.

    Article  PubMed  PubMed Central  Google Scholar 

  112. Vanderpool RC, Cohen EL, Crosby RA, et al. “1-2-3 Pap” intervention improves HPV vaccine series completion among Appalachian women. J Commun. 2013;63(1):95–115.

    Article  PubMed  PubMed Central  Google Scholar 

  113. Lewis RM, Markowitz LE, Gargano JW, Steinau M, Unger ER. Prevalence of genital human papillomavirus among sexually experienced males and females aged 14–59 years, United States, 2013–2014. J Infect Dis. 2018;217(6):869–77.

    Article  PubMed  Google Scholar 

  114. Park MJ, Mulye TP, Adams SH, Brindis CD, Irwin CE Jr. The health status of young adults in the United States. J Adolesc Health. 2006;39(3):305–17.

    Article  PubMed  Google Scholar 

  115. Barnard M, George P, Perryman ML, Wolff LA. Human papillomavirus (HPV) vaccine knowledge, attitudes, and uptake in college students: implications from the Precaution Adoption Process Model. PLoS One. 2017;12(8):e0182266.

    Article  PubMed  PubMed Central  Google Scholar 

  116. Hoerster KD, Lehavot K, Simpson T, McFall M, Reiber G, Nelson KM. Health and health behavior differences: US military, veteran, and civilian men. Am J Prev Med. 2012;43(5):483–9.

    Article  PubMed  Google Scholar 

  117. Martinez G. Use of family planning and related medical services among women aged 15–44 in the United States: National Survey of Family Growth, 2006–2010. Washington, DC: US Department of Health and Human Services, Centers for Disease Control and …; 2013.

    Google Scholar 

  118. Curry SJ, Krist AH, Owens DK, et al. Screening for cervical cancer: US Preventive Services Task Force recommendation statement. JAMA. 2018;320(7):674–86.

    Article  PubMed  Google Scholar 

  119. Hopfer S, Clippard JR. College women’s HPV vaccine decision narratives. Qual Health Res. 2011;21(2):262–77.

    Article  PubMed  Google Scholar 

  120. Klosky JL, Hudson MM, Chen Y, et al. Human papillomavirus vaccination rates in young cancer survivors. J Clin Oncol. 2017;35(31):3582.

    Article  PubMed  PubMed Central  Google Scholar 

  121. Castellino SM, Allen KE, Pleasant K, Keyes G, Poehling KA, Tooze JA. Suboptimal uptake of human papillomavirus (HPV) vaccine in survivors of childhood and adolescent and young adult (AYA) cancer. J Cancer Surviv. 2019;13(5):730–8.

    Article  PubMed  PubMed Central  Google Scholar 

  122. Preston SM, Darrow WW. Are men being left behind (or catching up)? Differences in HPV awareness, knowledge, and attitudes between diverse college men and women. Am J Mens Health. 2019;13(6):1557988319883776.

    Article  PubMed  PubMed Central  Google Scholar 

  123. Thompson EL, Vamos CA, Piepenbrink R, et al. Human papillomavirus risk perceptions and relationship status: a barrier to HPV vaccination? J Behav Med. 2019;42(5):991–7.

    Article  PubMed  Google Scholar 

  124. Best AL, Thompson EL, Adamu AM, et al. Examining the influence of religious and spiritual beliefs on HPV vaccine uptake among college women. J Relig Health. 2019;58(6):2196–207.

    Article  PubMed  PubMed Central  Google Scholar 

  125. Agénor M, Jahn JL, Kay E, et al. Human papillomavirus risk perceptions among young adult sexual minority cisgender women and nonbinary individuals assigned female at birth. Perspect Sex Reprod Health. 2019;51(1):27–34.

    Article  PubMed  Google Scholar 

  126. Hopfer S. Effects of a narrative HPV vaccination intervention aimed at reaching college women: a randomized controlled trial. Prev Sci. 2012;13(2):173–82.

    Article  PubMed  Google Scholar 

  127. The Community Guide. Vaccination programs: community-based interventions implemented in combination. 2015.

    Google Scholar 

  128. Chao C, Preciado M, Slezak J, Xu L. A randomized intervention of reminder letter for human papillomavirus vaccine series completion. J Adolesc Health. 2015;56(1):85–90.

    Article  PubMed  Google Scholar 

  129. Ruffin MT, Plegue MA, Rockwell PG, Young AP, Patel DA, Yeazel MW. Impact of an electronic health record (EHR) reminder on human papillomavirus (HPV) vaccine initiation and timely completion. J Am Board Fam Med. 2015;28(3):324–33.

    Article  PubMed  PubMed Central  Google Scholar 

  130. American College Health Association. Healthy Campus. Student objectives. 2020. https://www.acha.org/HealthyCampus/HealthyCampus/Student_Objectives.aspx

  131. IOM (Institute of Medicine). 2011. The Health of Lesbian, Gay, Bisexual, and Transgender People: Building a Foundation for Better Understanding. Washington, DC: The National Academies Press.

    Google Scholar 

  132. Palefsky J. Human papillomavirus and anal neoplasia. Curr HIV/AIDS Rep. 2008;5(2):78.

    Article  PubMed  Google Scholar 

  133. Colón-López V, Shiels MS, Machin M, et al. Anal cancer risk among people with HIV infection in the United States. J Clin Oncol. 2018;36(1):68.

    Article  PubMed  Google Scholar 

  134. Gerend MA, Madkins K, Gregory Phillips I, Mustanski B. Predictors of human papillomavirus vaccination among young men who have sex with men. Sex Transm Dis. 2016;43(3):185.

    Article  PubMed  PubMed Central  Google Scholar 

  135. Reiter PL, Katz ML, Bauermeister JA, Shoben AB, Paskett ED, McRee A-L. Increasing human papillomavirus vaccination among young gay and bisexual men: a randomized pilot trial of the outsmart HPV intervention. LGBT Health. 2018;5(5):325–9.

    Article  PubMed  PubMed Central  Google Scholar 

  136. Eaton L, Kalichman S, Cain D, et al. Perceived prevalence and risks for human papillomavirus (HPV) infection among women who have sex with women. J Women’s Health. 2008;17(1):75–84.

    Article  Google Scholar 

  137. Chido-Amajuoyi OG, Shete S, Talluri R. Prevalence of abnormal cervical cancer screening outcomes among women in the United States: results from the National Health Interview Survey, 2018. Am J Obstet Gynecol. 2020;223(6):938–41.

    Article  PubMed  Google Scholar 

  138. Grasso C, Goldhammer H, Brown RJ, Furness B. Using sexual orientation and gender identity data in electronic health records to assess for disparities in preventive health screening services. Int J Med Inform. 2020;142:104245.

    Article  PubMed  PubMed Central  Google Scholar 

  139. Braun H, Nash R, Tangpricha V, Brockman J, Ward K, Goodman M. Cancer in transgender people: evidence and methodological considerations. Epidemiol Rev. 2017;39(1):93–107.

    Article  PubMed  PubMed Central  Google Scholar 

  140. Reiter PL, McRee A-L, Katz ML, Paskett ED. Human papillomavirus vaccination among young adult gay and bisexual men in the United States. Am J Public Health. 2015;105(1):96–102.

    Article  PubMed  PubMed Central  Google Scholar 

  141. Polek C, Hardie T. Changing HPV vaccination rates in bisexual and lesbian women. J Am Assoc Nurse Pract. 2017;29(6):333–9.

    Article  PubMed  Google Scholar 

  142. Control CfD, Prevention. Recommendations on the use of quadrivalent human papillomavirus vaccine in males – advisory committee on immunization practices (ACIP), 2011. MMWR Morb Mortal Wkly Rep. 2011;60(50):1705–8.

    Google Scholar 

  143. Petrosky E, Bocchini JA Jr, Hariri S, et al. Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the advisory committee on immunization practices. MMWR Morb Mortal Wkly Rep. 2015;64(11):300.

    PubMed  PubMed Central  Google Scholar 

  144. Cummings T, Kasting ML, Rosenberger JG, Rosenthal SL, Zimet GD, Stupiansky NW. Catching up or missing out? Human papillomavirus vaccine acceptability among 18-to 26-year-old men who have sex with men in a US national sample. Sex Transm Dis. 2015;42(11):601–6.

    Article  CAS  PubMed  Google Scholar 

  145. Centers for Disease Control. National HIV Behavioral Surveillance (NHBS) | Surveillance Systems | Statistics Center | HIV/AIDS | CDC. 2020.

    Google Scholar 

  146. Meites E, Markowitz LE, Paz-Bailey G, Oster AM, Group NS. HPV vaccine coverage among men who have sex with men – National HIV Behavioral Surveillance System, United States, 2011. Vaccine. 2014;32(48):6356–9.

    Article  PubMed  PubMed Central  Google Scholar 

  147. Oliver SE, Hoots BE, Paz-Bailey G, Markowitz LE, Meites E, Group NS. Increasing human papillomavirus vaccine coverage among men who have sex with men—National HIV Behavioral Surveillance, United States, 2014. J Acquir Immune Defic Syndr (1999). 2017;75(Suppl 3):S370.

    Article  Google Scholar 

  148. Charlton BM, Reisner SL, Agénor M, Gordon AR, Sarda V, Austin SB. Sexual orientation disparities in human papillomavirus vaccination in a longitudinal cohort of US males and females. LGBT Health. 2017;4(3):202–9.

    Article  PubMed  PubMed Central  Google Scholar 

  149. Agénor M, Peitzmeier S, Gordon AR, Haneuse S, Potter JE, Austin SB. Sexual orientation identity disparities in awareness and initiation of the human papillomavirus vaccine among US women and girls: a national survey. Ann Intern Med. 2015;163(2):99–106.

    Article  PubMed  PubMed Central  Google Scholar 

  150. McRee A-L, Katz ML, Paskett ED, Reiter PL. HPV vaccination among lesbian and bisexual women: findings from a national survey of young adults. Vaccine. 2014;32(37):4736–42.

    Article  PubMed  PubMed Central  Google Scholar 

  151. Gorbach PM, Cook R, Gratzer B, et al. Human papillomavirus vaccination among young men who have sex with men and transgender women in 2 US cities, 2012–2014. Sex Transm Dis. 2017;44(7):436.

    Article  PubMed  PubMed Central  Google Scholar 

  152. Brown B, Poteat T, Marg L, Galea JT. Human papillomavirus-related cancer surveillance, prevention, and screening among transgender men and women: neglected populations at high risk. LGBT Health. 2017;4(5):315–9.

    Article  PubMed  Google Scholar 

  153. Gutierrez B Jr, Leung A, Jones KT, et al. Acceptability of the human papillomavirus vaccine among urban adolescent males. Am J Mens Health. 2013;7(1):27–36.

    Article  PubMed  Google Scholar 

  154. Wheldon CW, Daley EM, Buhi ER, Nyitray AG, Giuliano AR. Health beliefs and attitudes associated with HPV vaccine intention among young gay and bisexual men in the southeastern United States. Vaccine. 2011;29(45):8060–5.

    Article  PubMed  Google Scholar 

  155. Apaydin KZ, Fontenot HB, Shtasel D, et al. Facilitators of and barriers to HPV vaccination among sexual and gender minority patients at a Boston community health center. Vaccine. 2018;36(26):3868–75.

    Article  PubMed  PubMed Central  Google Scholar 

  156. Reiter PL, Brewer NT, McRee A-L, Gilbert P, Smith JS. Acceptability of HPV vaccine among a national sample of gay and bisexual men. Sex Transm Dis. 2010;37(3):197.

    Article  PubMed  PubMed Central  Google Scholar 

  157. Gilbert P, Brewer NT, Reiter PL, Ng TW, Smith JS. HPV vaccine acceptability in heterosexual, gay, and bisexual men. Am J Mens Health. 2011;5(4):297–305.

    Article  PubMed  Google Scholar 

  158. Daley EM, Vamos CA, Zimet GD, Rosberger Z, Thompson EL, Merrell L. The feminization of HPV: reversing gender biases in US human papillomavirus vaccine policy. Am J Public Health. 2016;106(6):983.

    Article  PubMed  PubMed Central  Google Scholar 

  159. Smalley KB, Warren JC, Barefoot KN. LGBT health: meeting the needs of gender and sexual minorities. Cham: Springer; 2017.

    Book  Google Scholar 

  160. Meites E, Krishna NK, Markowitz LE, Oster AM. Health care use and opportunities for human papillomavirus vaccination among young men who have sex with men. Sex Transm Dis. 2013;40(2):154.

    Article  PubMed  PubMed Central  Google Scholar 

  161. Stupiansky NW, Liau A, Rosenberger J, et al. Young men’s disclosure of same sex behaviors to healthcare providers and the impact on health: results from a US national sample of young men who have sex with men. AIDS Patient Care STDs. 2017;31(8):342–7.

    Article  PubMed  Google Scholar 

  162. McRee A-L, Reiter PL, Chantala K, Brewer NT. Does framing human papillomavirus vaccine as preventing cancer in men increase vaccine acceptability? Cancer Epidemiol Prev Biomarkers. 2010;19(8):1937–44.

    Article  Google Scholar 

  163. Rosario M, Schrimshaw EW, Hunter J. Predicting different patterns of sexual identity development over time among lesbian, gay, and bisexual youths: a cluster analytic approach. Am J Community Psychol. 2008;42(3–4):266–82.

    Article  PubMed  PubMed Central  Google Scholar 

  164. Preston SM, Darrow WW. Improving human papillomavirus-related knowledge and attitudes among ethnically diverse young adults. Health Equity. 2019;3(1):254–63.

    Article  PubMed  PubMed Central  Google Scholar 

  165. Juraskova I, Bari RA, O’Brien MT, McCaffery KJ. HPV vaccine promotion: does referring to both cervical cancer and genital warts affect intended and actual vaccination behavior? Womens Health Issues. 2011;21(1):71–9.

    Article  PubMed  Google Scholar 

  166. Moore GR, Crosby RA, Young A, Charnigo R. Low rates of free human papillomavirus vaccine uptake among young women. Sex Health. 2010;7(3):287–90.

    Article  PubMed  Google Scholar 

  167. Navarrete JP, Padilla ME, Castro LP, Rivera JO. Development of a community pharmacy human papillomavirus vaccine program for underinsured university students along the United States/Mexico border. J Am Pharm Assoc. 2014;54(6):642–7.

    Article  Google Scholar 

  168. Pahud B, Clark S, Herigon JC, et al. A pilot program to improve vaccination status for hospitalized children. Hosp Pediatr. 2015;5(1):35–41.

    Article  PubMed  Google Scholar 

  169. Gerend MA, Shepherd JE. Predicting human papillomavirus vaccine uptake in young adult women: comparing the health belief model and theory of planned behavior. Ann Behav Med. 2012;44(2):171–80.

    Article  PubMed  Google Scholar 

  170. Szilagyi PG, Humiston SG, Gallivan S, Albertin C, Sandler M, Blumkin A. Effectiveness of a citywide patient immunization navigator program on improving adolescent immunizations and preventive care visit rates. Arch Pediatr Adolesc Med. 2011;165(6):547–53.

    Article  PubMed  Google Scholar 

  171. Kharbanda EO, Stockwell MS, Fox HW, Andres R, Lara M, Rickert VI. Text message reminders to promote human papillomavirus vaccination. Vaccine. 2011;29(14):2537–41.

    Article  PubMed  Google Scholar 

  172. Matheson EC, Derouin A, Gagliano M, Thompson JA, Blood-Siegfried J. Increasing HPV vaccination series completion rates via text message reminders. J Pediatr Health Care. 2014;28(4):e35–9.

    Article  PubMed  Google Scholar 

  173. Patel A, Stern L, Unger Z, et al. Staying on track: a cluster randomized controlled trial of automated reminders aimed at increasing human papillomavirus vaccine completion. Vaccine. 2014;32(21):2428–33.

    Article  PubMed  Google Scholar 

  174. Perkins R, Zisblatt L, Legler A, Trucks E, Hanchate A, Gorin S. Effectiveness of a provider-focused intervention to improve HPV vaccination rates in boys and girls. Vaccine. 2015;33(9):7.

    Article  Google Scholar 

  175. Reiter PL, Gower AL, Kiss DE, et al. A web-based human papillomavirus vaccination intervention for young gay, bisexual, and other men who have sex with men: protocol for a randomized controlled trial. JMIR Res Protoc. 2020;9(2):e16294.

    Article  PubMed  PubMed Central  Google Scholar 

  176. McRee A-L, Shoben A, Bauermeister JA, Katz ML, Paskett ED, Reiter PL. Outsmart HPV: acceptability and short-term effects of a web-based HPV vaccination intervention for young adult gay and bisexual men. Vaccine. 2018;36(52):8158–64.

    Article  PubMed  PubMed Central  Google Scholar 

  177. Halkitis PN, Valera P, LoSchiavo CE, et al. Human papillomavirus vaccination and infection in young sexual minority men: the P18 cohort study. AIDS Patient Care STDs. 2019;33(4):149–56.

    Article  PubMed  PubMed Central  Google Scholar 

  178. Shah PD, Gilkey MB, Pepper JK, Gottlieb SL, Brewer NT. Promising alternative settings for HPV vaccination of US adolescents. Expert Rev Vaccines. 2014;13(2):235–46.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  179. Brewer NT, Chung JK, Baker HM, Rothholz MC, Smith JS. Pharmacist authority to provide HPV vaccine: novel partners in cervical cancer prevention. Gynecol Oncol. 2014;132:S3–8.

    Article  PubMed  Google Scholar 

  180. McRee A-L, Reiter PL, Pepper JK, Brewer NT. Correlates of comfort with alternative settings for HPV vaccine delivery. Hum Vaccin Immunother. 2013;9(2):306–13.

    Article  PubMed  PubMed Central  Google Scholar 

  181. Calo WA, Gilkey MB, Shah P, Marciniak MW, Brewer NT. Parents’ willingness to get human papillomavirus vaccination for their adolescent children at a pharmacy. Prev Med. 2017;99:251–6.

    Article  PubMed  PubMed Central  Google Scholar 

  182. Hastings TJ, Hohmann LA, McFarland SJ, Teeter BS, Westrick SC. Pharmacists’ attitudes and perceived barriers to human papillomavirus (HPV) vaccination services. Pharmacy. 2017;5(3):45.

    Article  PubMed  PubMed Central  Google Scholar 

  183. Cebollero J, Walton SM, Cavendish L, Quairoli K, Cwiak C, Kottke MJ. Evaluation of human papillomavirus vaccination after pharmacist-led intervention: a pilot project in an ambulatory clinic at a large academic urban medical center. Public Health Rep. 2020;135(3):313–21.

    Article  PubMed  PubMed Central  Google Scholar 

  184. Federico SG, Abrams L, Everhart RM, Melinkovich P, Hambidge SJ. Addressing adolescent immunization disparities: a retrospective analysis of school-based health center immunization delivery. Am J Public Health. 2010;100(9):1630–4.

    Article  PubMed  PubMed Central  Google Scholar 

  185. Moss JL, Feld AL, O’Malley B, et al. Opportunities for increasing human papillomavirus vaccine provision in school health centers. J Sch Health. 2014;84(6):370–8.

    Article  PubMed  PubMed Central  Google Scholar 

  186. Cheffins T, De La Rue S, Reeve C, Culpan M. School-based vaccinations delivered by general practice in rural North Queensland: an evaluation of a new human papillomavirus vaccination program. Commun Dis Intell Q Rep. 2008;32(1):94.

    PubMed  Google Scholar 

  187. Ogilvie G, Anderson M, Marra F, et al. A population-based evaluation of a publicly funded, school-based HPV vaccine program in British Columbia, Canada: parental factors associated with HPV vaccine receipt. PLoS Med. 2010;7(5):e1000270.

    Article  PubMed  PubMed Central  Google Scholar 

  188. Watson M, Shaw D, Molchanoff L, McInnes C. Challenges, lessons learned and results following the implementation of a human papilloma virus school vaccination program in South Australia. Aust N Z J Public Health. 2009;33(4):365–70.

    Article  PubMed  Google Scholar 

  189. Walker KK, Jackson RD, Sommariva S, Neelamegam M, Desch J. USA dental health providers’ role in HPV vaccine communication and HPV-OPC protection: a systematic review. Hum Vaccin Immunother. 2019;15(7–8):1863–9.

    Article  PubMed  PubMed Central  Google Scholar 

  190. Vázquez-Otero C, Vamos CA, Thompson EL, et al. Assessing dentists’ human papillomavirus-related health literacy for oropharyngeal cancer prevention. J Am Dent Assoc. 2018;149(1):9–17.

    Article  PubMed  Google Scholar 

  191. Griner SB, Thompson EL, Vamos CA, et al. Dental opinion leaders’ perspectives on barriers and facilitators to HPV-related prevention. Hum Vaccin Immunother. 2019;15(7–8):1856–62.

    Article  PubMed  PubMed Central  Google Scholar 

  192. Lazalde GE, Gilkey MB, Kornides ML, McRee A-L. Parent perceptions of dentists’ role in HPV vaccination. Vaccine. 2018;36(4):461–6.

    Article  PubMed  Google Scholar 

  193. Murthy N, Rodgers L, Pabst L, Fiebelkorn AP, Ng T. Progress in childhood vaccination data in immunization information systems—United States, 2013–2016. MMWR Morb Mortal Wkly Rep. 2017;66(43):1178.

    Article  PubMed  PubMed Central  Google Scholar 

  194. Groom H, Hopkins DP, Pabst LJ, et al. Immunization information systems to increase vaccination rates: a community guide systematic review. J Public Health Manag Pract. 2015;21(3):227–48.

    Article  PubMed  Google Scholar 

  195. Centers for Disease Control and Prevention. 2013–2018 immunization information functional standards 2019. https://www.cdc.gov/vaccines/programs/iis/functional-standards/func-stds-2013-2018.html

  196. Szilagyi P, Albertin C, Gurfinkel D, et al. Effect of state immunization information system centralized reminder and recall on HPV vaccination rates. Pediatrics. 2020;145(5):e20192689.

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

The authors of the chapter wish to thank Mary Katherine Haver, MLIS, AHIP, Medical Librarian, at the Moffitt Cancer Center Biomedical Library for conducting an initial search for articles for this chapter.

Author information

Authors and Affiliations

  1. H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA

    Shannon M. Christy, Lindsay N. Fuzzell, Paige W. Lake & Susan T. Vadaparampil

  2. University of Florida, Gainesville, FL, USA

    Stephanie Staras

  3. University of Puerto Rico, San Juan, Puerto Rico

    Vivian Colon Lopez

  4. College of Public Health, University of South Florida, Tampa, FL, USA

    Alicia Best

  5. Markey Cancer Center, Community Impact Office, University of Kentucky, Lexington, KY, USA

    Pamela C. Hull

Authors
  1. Shannon M. Christy
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Lindsay N. Fuzzell
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Paige W. Lake
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Stephanie Staras
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Vivian Colon Lopez
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Alicia Best
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Pamela C. Hull
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Susan T. Vadaparampil
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Shannon M. Christy .

Editor information

Editors and Affiliations

  1. University of Southern California, California, CA, USA

    Chanita Hughes Halbert, PhD

Rights and permissions

Reprints and permissions

Copyright information

© 2023 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Christy, S.M. et al. (2023). Community-Based Interventions for HPV Vaccination. In: Hughes Halbert, PhD, C. (eds) Cancer Health Disparities. Springer, Cham. https://doi.org/10.1007/978-3-031-37638-2_10

Download citation

Publish with us

Policies and ethics

Search

Navigation